Skip to main content
Equibles

Moran Wealth Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 1965334 Naples, FL
Back to EXEL Full portfolio

Position in EXEL

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$7,679,970
+$4,939,085 QoQ
Shares Held
141,150
+120.9% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#143
of 756 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 99% Shared 1% None 0%

Common Shares in EXEL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Moran Wealth Management, LLC holds $37,590,704 across 10 Biotechnology names. EXEL ranks #2 (20.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 186,672 $10,466,698
2 EXEL
Exelixis, Inc.
This page 		141,150 $7,679,970
3 HALO
Halozyme Therapeutics, Inc.
 80,381 $6,291,420
4 LGND
Ligand Pharmaceuticals Inc
 19,790 $6,255,420
5 REGN
Regeneron Pharmaceuticals, Inc.
 4,300 $2,681,221
6 CRSP
CRISPR Therapeutics AG
 35,374 $1,929,297
7 STOK
Stoke Therapeutics, Inc.
 47,977 $1,569,807
8 RNA
Atrium Therapeutics, Inc.
 33,320 $448,154

All Filings in EXEL

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,679,970 141,150
2026-03-31 $2,740,885 63,905
2025-12-31 $3,019,536 68,892
2025-09-30 $2,966,042 71,817
2025-06-30 $4,201,352 95,312
2025-03-31 $3,443,602 93,272
2024-12-31 $935,263 28,086
2024-09-30 $777,098 29,946
2024-06-30 $423,042 18,827
2024-03-31 $281,390 11,858